Tag: interim

TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million

TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Group”; stock code: 1875.HK), a biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its unaudited interim results for the six months ended 30 June 2021. KEY MILESTONES IN 2021 1HIn the first half of 2021, on the back of by national policies and driven by innovative R&D, the oncology drug market in China boomed and continued to gather growth momentum. The Group continued to implement its strategic plans drawing on its own strengths and competitive advantages, striving to become a leading player in the domestic ... Read more

PFC pays interim dividend of Rs 1182.63 crore to Government of India for the financial year 2020-21

Power Finance Corporation, a Navratna Central Public Sector Enterprise under Ministry of Power  and India’s leading NBFC for the Power Sector has paid an interim dividend of Rs 1182.63 crore to Government of India for the financial year 2020-21 on March 31st, 2021 on 1,47,82,91,778 number of equity shares (56%) held by the government. Shri Ravinder Singh Dhillon, CMD, PFC presenting bank advice of an interim dividend of Rs 1182.63 crore to Shri R.K. Singh,  Minister of State (Independent Charge) Power and New & Renewable Energy & Minister of State for Skill Development and Entrepreneurship The interim dividend RTGS intimation ... Read more